Hepatic kinome atlas: An in‐depth identification of kinase pathways in liver fibrosis of humans and rodents. Issue 5 (8th April 2022)

• Record Type: Journal Article
• Authors: Creeden, Justin F.; Kipp, Zachary A.; Xu, Mei; Flight, Robert M.; Moseley, Hunter N. B.; Martinez, Genesee J.; Lee, Wang‐Hsin; Alganem, Khaled; Imami, Ali S.; McMullen, Megan R.; Roychowdhury, Sanjoy; Nawabi, Atta M.; Hipp, Jennifer A.; Softic, Samir; Weinman, Steven A.; McCullumsmith, Robert; Nagy, Laura E.; Hinds, Terry D.
• Is Part Of: Hepatology. Volume 76:Issue 5(2022)
• Page Start: 1376
• Page End: 1388
• Publication Date: 2022-04-08
• Subjects: Heart -- Diseases -- Nursing -- Periodicals; Lungs -- Diseases -- Nursing -- Periodicals; Intensive care nursing -- Periodicals; Foie -- Maladies -- Périodiques; 616.362
• DOI: 10.1002/hep.32467
• Languages: English
• ISSNs: 0270-9139

Abstract

Abstract: Background and Aims: Resolution of pathways that converge to induce deleterious effects in hepatic diseases, such as in the later stages, have potential antifibrotic effects that may improve outcomes. We aimed to explore whether humans and rodents display similar fibrotic signaling networks. Approach and Results: We assiduously mapped kinase pathways using 340 substrate targets, upstream bioinformatic analysis of kinase pathways, and over 2000 random sampling iterations using the PamGene PamStation kinome microarray chip technology. Using this technology, we characterized a large number of kinases with altered activity in liver fibrosis of both species. Gene expression and immunostaining analyses validated many of these kinases as bona fide signaling events. Surprisingly, the insulin receptor emerged as a considerable protein tyrosine kinase that is hyperactive in fibrotic liver disease in humans and rodents. Discoidin domain receptor tyrosine kinase, activated by collagen that increases during fibrosis, was another hyperactive protein tyrosine kinase in humans and rodents with fibrosis. The serine/threonine kinases found to be the most active in fibrosis were dystrophy type 1 protein kinase and members of the protein kinase family of kinases. We compared the fibrotic events over four models: humans with cirrhosis and three murine models with differing levels of fibrosis, including two models of fatty liver disease with emerging fibrosis. The data demonstrate a high concordance between human and rodent hepatic kinome signaling that focalizes, as shown by our network analysis of detrimental pathways. Conclusions: Our findings establish a comprehensive kinase atlas for liver fibrosis, which identifies analogous signaling events conserved among humans and rodents. Abstract : We compared human and mouse liver fibrosis with kinase activity measurements using the PamGene PamStation technology and bioinformatic analysis. The Insulin Receptor (INSR), DDR, DMPK, and PKA are the most active kinases among humans with cirrhosis and animal models of fibrosis.